Génomic Vision SAの内部者の所有権
Génomic Vision SAの内部者の所有権は何ですか。
Génomic Vision SAの内部者の所有権は7.13%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
EURONEXTのセクタHealth Careにおける内部者の所有権の企業と比べるGénomic Vision SA
Génomic Vision SAは何をしますか。
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Génomic Vision SAと類似の内部者の所有権
- Cardiff Oncologyの内部者の所有権は7.12%です。
- Zymeworks BC Incの内部者の所有権は7.12%です。
- Bay Banks of Virginiaの内部者の所有権は7.13%です。
- Bellevue Goldの内部者の所有権は7.13%です。
- Bellevue Goldの内部者の所有権は7.13%です。
- Berkeley Energiaの内部者の所有権は7.13%です。
- Génomic Vision SAの内部者の所有権は7.13%です。
- NexPoint Real Estate Finance Incの内部者の所有権は7.13%です。
- Aurora Investment Trustの内部者の所有権は7.14%です。
- Headlam Plcの内部者の所有権は7.14%です。
- Real Mattersの内部者の所有権は7.15%です。
- Real Mattersの内部者の所有権は7.15%です。
- Yellow Cake plcの内部者の所有権は7.15%です。